Cancer Biology & Medicine

Papers
(The H4-Index of Cancer Biology & Medicine is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study138
The Warburg effect drives dedifferentiation through epigenetic reprogramming71
Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up46
Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical cente44
ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis43
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II tria40
SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation34
ENO1 expression and Erk phosphorylation in PDAC and their effects on tumor cell apoptosis in a hypoxic microenvironment33
Cancer stem cells: a target for overcoming therapeutic resistance and relapse32
Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer32
Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis31
Associations between polymorphisms in leptin and leptin receptor genes and colorectal cancer survival27
PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer25
Chinese Society of Clinical Oncology Non-small Cell Lung Cancer (CSCO NSCLC) guidelines in 2024: key update on the management of early and locally advanced NSCLC21
Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies21
Nodal peripheral T-cell lymphomas in the new classification systems20
Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a20
Immune checkpoint inhibitors: breakthroughs in cancer treatment20
Advances in lung cancer screening and early detection19
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity19
Facing challenges with hope: universal immune cells for hematologic malignancies19
1.418251991272